On-Demand Webinars

  1. How Iteration And Operational Readiness Accelerate Product-To-Patient 5/20/2026

    See how an iterative, risk‑based approach to Commissioning & Qualification shifts verification earlier, reduces late‑stage pressure, and supports smoother startups through operational readiness.

  2. Cell And Gene Therapies – U.S. Payer Trends 5/20/2026

    Gain insights from U.S. payer interviews covering coverage processes, evidence requirements, and engagement strategies to accelerate market access from late-stage development through commercialization.

  3. The Transformative Potential Of AI In HEOR And Market Access 5/20/2026

    HEOR teams are under pressure to move faster without sacrificing rigor. Discover how AI accelerates evidence synthesis, fills data gaps, and supports living models that meet HTA transparency standards.

  4. The Evolving Policy Landscape: U.S. And EU Pricing And Access 5/20/2026

    U.S. and EU policy shifts are reshaping pricing, access, and launch strategy. Hear expert analysis on IRA, MFN, 340B, EU HTA Regulation, and the Biotech Act to stay ahead of 2025-2026 changes.

  5. Building The Right Foundation - Live Cell Assays In Clinical Trials 5/19/2026

    Watch Thomas (TJ) Beadnell share expert insights on developing robust live cell assays for global clinical trials, including best practices for assay logistics, antigen stability, and sample integrity.

  6. A Blueprint For Clinical-Grade Gene Therapy Production 5/19/2026

    View a scalable, open-access AAV9 manufacturing process improving yield, purity, and consistency through optimized transfection and downstream purification for clinical-grade gene therapy production.

  7. Evaluating The Entire Package System Under USP 382 5/18/2026

    USP 382 introduces holistic packaging evaluation, focusing on container closure integrity, functionality, and real-world conditions to ensure sterility, safety, and product reliability.

  8. Understanding The Regulatory Landscape For Ophthalmic Drug Products 5/14/2026

    Learn how evolving ophthalmic regulations, contamination control strategies, and advanced packaging solutions can help support compliance, product quality, and patient safety.

  9. Strategic Early Material Generation For Accelerated Process Development 5/14/2026

    Learn how early material generation strategies can accelerate biologics development, streamline process optimization, and enable scalable, production-relevant material supply from the earliest stages of development.

  10. Foundations And Implications For International Reference Pricing 5/14/2026

    Reforms like the U.S. Most Favored Nation model are intensifying pressure on global launch strategies. Understand the tactics that protect value while expanding access.